Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07112144 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The immunogenicity and safety of the adsorption of cell-free diphtheria and tetanus (three-component) combined vaccine were evaluated at 2 months, 4 months and 6 months.
Trial Details
NCT Number NCT07112144
Lead Sponsor Changchun BCHT Biotechnology Co.
Collaborators: Yunnan Provincial Center for Disease Control and Prevention, Shaanxi Provincial Center for Disease Control and Prevention, Guizhou Provincial Center for Disease Control and Prevention, Shandong Provincial Center for Disease Control and Prevention
Conditions
(from sponsor)		 Prevent Whooping Cough, Prevent Diphtheria, Prevent Tetanus
Enrollment 1,650 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov